FDA 483 - Beta Bionics, Inc - June 26, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Beta Bionics, Inc. in Irvine, CA, was cited for significant deficiencies in its quality system, particularly concerning medical device reporting, complaint handling, corrective and preventive actions, and risk analysis for its iLet Bionic Pancreas System. The inspection revealed failures to report serious injuries and malfunctions, inadequate investigation and documentation of product issues, and insufficient verification of corrective actions, posing potential risks to patient health.
ID · 9af47214-da73-462b-b636-d172b6317b0a